UPA is supporting
Disc Medicine and clinical study sites to support patient referrals for the APOLLO Study, a Phase 3 clinical trial evaluating Bitopertin, an investigational oral medication for individuals with
Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP).
This form helps us manage participant interest. Filling it out does not obligate you to participate. If you live in the U.S. or Canada, please complete the information below, and UPA will contact you with more details and next steps.
Your responses will remain confidential and will not be shared without your consent.